Global Bipolar Disorder Treatment Market – Industry Trends and Forecast to 2029

  • Pharmaceutical
  • Upcoming Report
  • Jan 2022
  • Global
  • 350 Pages
  • No of Tables: 60
  • No of Figures: 220

Global Bipolar Disorder Treatment Market, By Bipolar Disorders Type (Bipolar I and Bipolar II), Drug Class (Anticonvulsants, Antianxiety, Mood Stabilizers, Antipsychotic, Antidepressant and Others), Mechanism of Action (Selective Serotonin Reuptake Inhibitor, Serotonin Norepinephrine Reuptake Inhibitors, Tricyclic Antidepressants, Monoamine Oxidase Inhibitors, Benzodiazepines and Beta Blockers), Route of Administration (Oral, Parenteral and Others), End User (Hospitals, Homecare, Specialty Clinics, Others), Distribution Channel (Hospital Pharmacy, Online Pharmacy and Retail Pharmacy), Country (U.S., Canada, Mexico, Peru, Brazil, Argentina, Rest of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia Pacific, South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa) Industry Trends and Forecast to 2029.

Bipolar Disorder Treatment Market

Market Analysis and Insights of Bipolar Disorder Treatment Market

Data Bridge Market Research analyses that the bipolar disorder treatment will exhibit a CAGR of around 2.65% for the forecast period of 2022-2029. Growing demand for targeted mode of therapies, surge in the research and development activities for the development of novel drugs and therapies, increasing cases of bipolar disorder among population and increased expenditure for the development of healthcare infrastructure are the major factors attributable to the growth of bipolar disorder treatment market.

Also known as maniac depression, bipolar disorder is a medical condition associated with mental illness. Bipolar disorder is characterized by rapid mood swings and affects the mood, energy level, and other activities.

Growing special designation from regulatory authorities is a major factor fostering the growth of the market. Rising expenditure on the development of healthcare infrastructure, growing adoption of sedentary life-style, increase in the initiatives by the government to promote awareness in the backward areas, and upsurge in the strategic collaboration rate among the market players are other factors also fostering the growth of the market. Surging acceptance of society regarding mental illness is other determinant that will create lucrative market growth opportunities.

However, dearth of skilled medical professionals and unfavourable reimbursement scenario in the developing and under developed economies will pose a major challenge to the market growth. Also, high costs associated with research and development proficiencies, side effects such as blurred vision, damage to the liver, thyroid disorders among others, stringent regulatory frameworks, limited number of approved anticonvulsants and poor healthcare facilities in the underdeveloped economies will further derail the market growth rate.

This bipolar disorder treatment market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on bipolar disorder treatment market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Bipolar Disorder Treatment Market Scope and Market Size

The bipolar disorder treatment market is segmented on the basis of bipolar disorder type, drug class, mechanism of action, route of administration, distribution channel and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on bipolar disorders type, the bipolar disorder treatment market is segmented into bipolar I and bipolar II. Bipolar I disorder is a mixed or manic episode. Bipolar II disorder is mild depression and hypomania.
  • On the basis of drug class, the bipolar disorder treatment market is segmented into anticonvulsants, antianxiety, mood stabilizers, antipsychotic, antidepressant and others.
  • Bipolar disorder treatment market has also been segmented based on the mechanism of action into selective serotonin reuptake inhibitor, serotonin norepinephrine reuptake inhibitors, tricyclic antidepressants, monoamine oxidase inhibitors, benzodiazepines and beta blockers.
  • On the basis of route of administration, the bipolar disorder treatment market is segmented into oral, parenteral and others.
  • Based on end user, the bipolar disorder treatment market is segmented into hospitals, homecare, specialty clinics and others.
  • The distribution channel in the bipolar disorder treatment market is segmented into hospital pharmacy, online pharmacy and retail pharmacy.

Bipolar Disorder Treatment Market Country Level Analysis

The bipolar disorder treatment market is analysed and market size insights and trends are provided by country, bipolar disorder type, drug class, mechanism of action, route of administration and end user as referenced above.

The countries covered in the bipolar disorder treatment market report are U.S., Canada and Mexico in North America, Peru, Brazil, Argentina and Rest of South America as part of South America, Germany, Italy, U.K., France, Spain, Netherlands, Belgium, Switzerland, Turkey, Russia, Hungary, Lithuania, Austria, Ireland, Norway, Poland, Rest of Europe in Europe, Japan, China, India, South Korea, Australia, Singapore, Malaysia, Thailand, Indonesia, Philippines, Vietnam, Rest of Asia-Pacific (APAC) in Asia-Pacific (APAC), South Africa, Saudi Arabia, U.A.E, Kuwait, Israel, Egypt, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA).

North America dominates the bipolar disorder treatment market owing to the earliest adoption of innovative technologies, growing research and development capacities, augmented knowledge and larger accessibility of treatment alternatives. Asia-Pacific is projected to undergo substantial gains during the forecast period and score the highest CAGR. This is because of the rising expenditure to develop healthcare infrastructure, ever-rising geriatric population base, rising knowledge about the mental sickness and increase in the research and development activities.

The country section of the bipolar disorder treatment market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Patient Epidemiology Analysis

The bipolar disorder treatment market also provides you with detailed market analysis for patient analysis, prognosis and cures. Prevalence, incidence, mortality, adherence rates are some of the data variables that are available in the report. Direct or indirect impact analysis of epidemiology to bipolar disorder treatment market growth are analysed to create a more robust and cohort multivariate statistical model for forecasting the bipolar disorder treatment market in the growth period.

Competitive Landscape and Bipolar Disorder Treatment Market Share Analysis

The bipolar disorder treatment market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies’ focus related to bipolar disorder treatment market.

Some of the major players operating in the bipolar disorder treatment market are Johnson & Johnson Services, Inc., AbbVie Inc., Allergan, Mallinckrodt, Sun Pharmaceutical Industries Ltd., Novartis AG, Endo Pharmaceuticals plc, Zydus Cadila, Mylan N.V., Mayne Pharma Group Limited, Teva Pharmaceutical Industries Ltd, Amneal Pharmaceutical Inc., Avet Pharmaceuticals Inc., Lannett, Aurobindo Pharma, Wockhardt, Currax Pharmaceuticals LLC, AstraZeneca, F. Hoffmann-La Roche Ltd., and Eli Lilly and Company among others.

Customization Available : Global Bipolar Disorder Treatment Market

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customised to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analysed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.


SKU-

Please fill in the below form for detailed Table of Content

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Table

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

Please fill in the below form for detailed List of Figure

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions

CHOOSE LICENCE TYPE
  • 7000.00
  • 4800.00
  • 3000.00
  • 8000.00
  • 12000.00
Why Choose Us
Unlocking New Opportunities on this Report Post Covid-19

By clicking the "Submit" button, you are agreeing to the Data Bridge Market Research Privacy Policy and Terms and Conditions



Frequently Asked Questions